
### [NCIT:C18585](http://purl.obolibrary.org/obo/NCIT_C18585)
**Label:** KMT2A Gene

**Corr. equiv. classes:** [http://purl.obolibrary.org/obo/NCIT_C36365](NCIT:C36365) (t(4;11)(q21;q23)), [http://purl.obolibrary.org/obo/NCIT_C38390](NCIT:C38390) (MLLT3-KMT2A Fusion Protein Expression), 4a9493fa-8ec6-4901-aa35-9df8eed783bdf804b068-32ee-4b99-80cd-56af89e08270[http://purl.obolibrary.org/obo/NCIT_C122623](NCIT:C122623) (KMT2A Gene Rearrangement), [http://purl.obolibrary.org/obo/NCIT_C36371](NCIT:C36371) (t(11;19)(q23;p13.1)), [http://purl.obolibrary.org/obo/NCIT_C36366](NCIT:C36366) (t(9;11)(q21;q23)), [http://purl.obolibrary.org/obo/NCIT_C38391](NCIT:C38391) (KMT2A-ENL Fusion Protein Expression), 05a84030-0ce1-47fd-8c96-691993bdc655[http://purl.obolibrary.org/obo/NCIT_C37228](NCIT:C37228) (KMT2A-AF4 Fusion Protein Expression), df737067-4eb7-4815-b4f4-b16529a788bb[http://purl.obolibrary.org/obo/NCIT_C38393](NCIT:C38393) (KMT2A-EEN Fusion Protein Expression), 5638a22c-a191-42b7-bc55-42c45d6b4f81[http://purl.obolibrary.org/obo/NCIT_C36370](NCIT:C36370) (t(9;11)(p22.3;q23.3)), [http://purl.obolibrary.org/obo/NCIT_C45399](NCIT:C45399) (V-MLL Fusion Protein Expression), [http://purl.obolibrary.org/obo/NCIT_C38392](NCIT:C38392) (KMT2A-ELL Fusion Protein Expression), [http://purl.obolibrary.org/obo/NCIT_C38387](NCIT:C38387) (KMT2A-AF10 Fusion Protein Expression), [http://purl.obolibrary.org/obo/NCIT_C36517](NCIT:C36517) (t(v;11q23.3)), 9eaa09f8-d740-4bbf-b40d-b201a1a9a0ba[http://purl.obolibrary.org/obo/NCIT_C36372](NCIT:C36372) (t(11;19)(q23;p13.3)), 9b043d7a-6db3-457d-8bd7-f6ddfb8545b6

**Class expressions from DL-Learner:**

- [NCIT:C3910](http://purl.obolibrary.org/obo/NCIT_C3910) (Molecular Abnormality) 55.07%
- not ([CHEBI:16541](http://purl.obolibrary.org/obo/CHEBI_16541) (protein polypeptide chain)) 51.51%
- not ([CHEBI:17089](http://purl.obolibrary.org/obo/CHEBI_17089) (glycoprotein)) 51.51%
- not ([CHEBI:16990](http://purl.obolibrary.org/obo/CHEBI_16990) (bilirubin)) 51.51%
- not ([CHEBI:16336](http://purl.obolibrary.org/obo/CHEBI_16336) (hyaluronic acid)) 51.51%
- not ([CHEBI:15440](http://purl.obolibrary.org/obo/CHEBI_15440) (squalene)) 51.51%
- not ([CHEBI:10545](http://purl.obolibrary.org/obo/CHEBI_10545) (electron)) 51.51%
- Thing 51.51%
- not (CARO:0010000) 51.51%
- not ([BFO:0000020](http://purl.obolibrary.org/obo/BFO_0000020) (null)) 51.51%
- not ([BFO:0000019](http://purl.obolibrary.org/obo/BFO_0000019) (null)) 51.51%
- [NCIT:C36327](http://purl.obolibrary.org/obo/NCIT_C36327) (Gene Abnormality) 35.34%
- [NCIT:C36391](http://purl.obolibrary.org/obo/NCIT_C36391) (Molecular Genetic Variation) 34.76%
- [NCIT:C97926](http://purl.obolibrary.org/obo/NCIT_C97926) (Molecular Sequence Variation) 34.52%
- [NCIT:C36346](http://purl.obolibrary.org/obo/NCIT_C36346) (Fusion Protein Expression) 33.32%
- [NCIT:C36345](http://purl.obolibrary.org/obo/NCIT_C36345) (Protein Deregulation) 33.05%
- [NCIT:C36336](http://purl.obolibrary.org/obo/NCIT_C36336) (Deregulation of Protein and Messenger RNA Expression) 32.72%
- [NCIT:C3420](http://purl.obolibrary.org/obo/NCIT_C3420) (Chromosomal Translocation) 27.70%
- [NCIT:C36541](http://purl.obolibrary.org/obo/NCIT_C36541) (Chromosomal Rearrangement) 27.00%
- [NCIT:C2950](http://purl.obolibrary.org/obo/NCIT_C2950) (Cytogenetic Abnormality) 25.79%


